Sweet's Syndrome as a Possible Consequence of Azacitidine Subcutaneous Administration in IPSS Intermediate-2 Myelodysplastic Syndrome

Antonietta Troccola¹, Pasquale Fino^1*, Liliana De Santo¹, Federico Corrias¹, Paola Parisi¹, Massimo Breccia², Corrado Girmenia² and Maria Giuseppina Onesti¹

¹Department of Plastic, Reconstructive and Aesthetic Surgery, University of Rome “Sapienza”, Policlinico Umberto I, Viale del Policlinico, 155, 00161, Rome, Italy

²Department of Cellular Biotechnologies and Hematology, University of Rome “Sapienza”, Policlinico Umberto I, Viale del Policlinico, 155, 00161, Rome, Italy

^*Corresponding Author: